Is Pacira Biosciences, Inc. PCRX stock halal to invest in?

No, as of February 2026, Pacira Biosciences, Inc. stock (PCRX) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Pacira Biosciences, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Pacira Biosciences, Inc. and alternative halal stock options within the Tabadulat app.

How often is Pacira Biosciences, Inc. PCRX reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Pacira Biosciences, Inc. PCRX monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Pacira Biosciences, Inc. PCRX pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, Pacira Biosciences, Inc. stock (PCRX) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does Pacira Biosciences, Inc. PCRX pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Pacira Biosciences, Inc. stock (PCRX) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, Pacira Biosciences, Inc. stock (PCRX) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Pacira Biosciences, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

PCRX

About

Pacira Biosciences, Inc.

PCRX

Pacira BioSciences Inc. is a pharmaceutical company focused on delivering non-opioid pain management solutions. Its flagship product, EXPAREL, is a long-acting, local analgesic that releases bupivacaine to manage postoperative pain while reducing reliance on opioids. Pacira targets various sectors within healthcare, including hospitals, surgical centers, and pain management clinics, driving a paradigm shift towards minimizing opioid usage in surgical recovery and chronic pain settings. The company's innovation extends to iovera°, a cryoanalgesia treatment utilizing extreme cold to block nerves and reduce pain temporarily, further diversifying its pain management portfolio. Based in Parsippany, New Jersey, Pacira BioSciences plays a crucial role in addressing the opioid epidemic by providing alternative pain management solutions, which align with broader public health initiatives seeking to improve patient outcomes and enhance post-surgical recovery protocols. Their contributions are significant in reducing opioid-related side effects and addiction risks, promoting the adoption of safer analgesic methods across medical practices.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Employees:

788

Website:

https://www.pacira.com

PCRX

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Pacira Biosciences, Inc.

About

Pacira Biosciences, Inc.

PCRX

Frequently asked questions

Is Pacira Biosciences, Inc. PCRX stock halal to invest in?

How often is Pacira Biosciences, Inc. PCRX reviewed for Shariah compliance?

Does Pacira Biosciences, Inc. PCRX pass the AAOIFI Non Permissible Income criteria?

Does Pacira Biosciences, Inc. PCRX pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Pacira Biosciences, Inc. PCRX stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.